Hyperphosphatemia Management in Patients with Chronic Kidney Disease

Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering condition that can lead to cardiovascular calcification, metabolic bone disease (renal osteodystrophy) and the development of secondary hyperparathyroidism (SHPT). It is also associated with increased prevalenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaman, Ahmed M., Kowalski, Stefan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908098/
https://www.ncbi.nlm.nih.gov/pubmed/27330380
http://dx.doi.org/10.1016/j.jsps.2015.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908098/
https://www.ncbi.nlm.nih.gov/pubmed/27330380
http://dx.doi.org/10.1016/j.jsps.2015.01.009

Ejemplares similares